Sato Pharmaceutical Inc.
Summary
- Total Recalls
- 8
- 510(k) Clearances
- 0
- Inspections
- 3
- Compliance Actions
- 0
Known Names
sato pharmaceutical co, sato pharmaceutical, sato pharmaceutical, co, sato pharmaceutical inc
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0323-2020 | Class III | Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceu | October 1, 2019 |
| D-0303-2020 | Class III | Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bott | October 1, 2019 |
| D-0325-2020 | Class III | Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Phar | October 1, 2019 |
| D-0324-2020 | Class III | WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 | October 1, 2019 |
| D-0322-2020 | Class III | Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutica | October 1, 2019 |
| D-0856-2017 | Class II | DORAMA-NEO (naphazoline hydrochloride) Eye wash, packaged in 0.5 FL OZ (15mL) bottles, Manufactured | February 16, 2017 |
| D-0855-2017 | Class II | SATO CLEAR (naphazoline hydrochloride) Redness Reliever Eye Drops, packaged in 0.5 FL OZ (15mL) bott | February 16, 2017 |
| D-0854-2017 | Class II | Optic Splash (naphazoline hydrochloride) Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactur | February 16, 2017 |